REGENXBIO Inc.
$6.065
USD
Last updated on --.
24h volume1.50M
24h highest6.9850 USD
24h lowest6.0000 USD
24h Price movement-0.25%
RGNX recent prices
24 Hours
-0.25%-$0.015
30 days
-42.51%-$4.485
60 days
-30.05%-$2.605
90 days
-41.57%-$4.315
Key data
Previous close6.0800 USD
Market cap362.40M USD
Volume1.50M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-5.6100 USD
Net income (FY)-290.01M USD
Revenue (FY)87.82M USD
Last report dateMay 14, 2026
About REGENXBIO Inc.
HeadquartersROCKVILLE
Employees (FY)371.00
Revenue per employee (FY)236.72K USD
Net income per employee (FY)-781.70K USD
Listed onNasdaq
RGNX conversion tables
 |  |
|---|---|
| 0.5 RGNX | 3.032 USD |
| 1 RGNX | 6.065 USD |
| 5 RGNX | 30.32 USD |
| 10 RGNX | 60.65 USD |
| |
|---|---|
| 0.5 USD | 0.08244 RGNX |
| 1 USD | 0.16488 RGNX |
| 5 USD | 0.8244 RGNX |
| 10 USD | 1.648 RGNX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
RGNX is trading at $6.065, -0.25% over the last 24 hours. Track live moves on the price chart at the top of this page.
The RGNX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. RGNX is currently trading at $6.065, -0.25% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on RGNX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. RGNX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from RGNX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against RGNX's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
REGENXBIO Inc.'s market cap is currently 362.40M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.50M
24h highest6.9850 USD
24h lowest6.0000 USD
24h Price movement-0.25%
Start trade with RGNX Perpetual
Sign up to trade